Skip to NavigationSkip to content

News

Tumours with a large number of DNA mutations are more likely to respond to immunotherapies than cancers with fewer mutations, according to new...
Verona Pharma has seen its shares crater following the Phase 2 failure of its nebulised ensifentrine, known as RPL554, in combination with...
Dutch health minister Bruno Bairns has called for a meeting with Swiss multinational Novartis after the multibillion-dollar firm introduced a five-...
Breast cancer patients in Scotland are set to receive an additional treatment option, as the Scottish Medicines Consortium announces its...
Congressman Elijah Cummings has launched an investigation into pharmaceutical pricing practices after requesting information from 12 multinational...
Seqirus has made it known that its new cell-based seasonal influenza vaccine Flucelvax Tetra has been approved by the European Commission for...
Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently inflating wholesale prices that went...
The British Government has come under fire over the appointment of former Tory MP, Nicola Blackwood, as a junior minister in the Department of...
2018 was a strong year for European approvals according to the EMA; the regulator has recently released its Human medicines highlights 2018,...
The Global Fund is seeking £11 billion worth of investment in an attempt to save 16 million lives in the fight against malaria, tuberculosis (TB)...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches